Navigation Links
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Date:7/1/2008

INDIANAPOLIS, July 1 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced it closed a $25 million Series B financing. New investor Care Capital led the round, which included previous investors Pappas Ventures, Domain Associates, Pearl Street Venture Funds and Triathlon Medical Ventures. The financing will be used to further develop a unique migraine compound, COL-144, and to advance a preclinical pipeline of novel chemical entities targeting neurological and psychiatric disorders.

COL-144 is a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA) designed to deliver efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapy. COL-144 selectively targets 5HT1F receptors expressed in the trigeminal nerve pathway. CoLucid completed a Phase II clinical trial last year examining the efficacy of COL-144 in the acute treatment of migraine after intravenous administration. The trial provided clear evidence of safe, effective alleviation of migraine pain and identified a range of doses that provided relief of migraine symptoms and were well tolerated. Based on these encouraging results, CoLucid is advancing clinical development of COL-144 as a treatment for migraine by the oral route of administration.

As a part of the Series B financing, CoLucid also announced the addition of Richard Markham, partner at Care Capital, to the Board of Directors. Prior to joining Care Capital, Markham held several senior leadership positions in the pharmaceutical industry, including CEO of Aventis Pharma, CEO of Hoechst Marion Roussel and President, COO and Board member of Marion Merrell Dow. In addition, he served as President and COO of Merck.

"COL-144 is the first in a new class of migraine therapeutics and represents a paradigm shift in the treatment of migraine," said James White, Ph.D., President and CE
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Catalent, ... development solutions for drugs, biologics and consumer health products, today announced that ... its antibody combination therapy (ACT) technology platform. The platform has the potential ...
(Date:7/7/2015)... ... 2015 , ... Safe Catch is setting revolutionary purity limits for canned tuna ... New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of the first ... every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... the experience for its patient community using its IDF ePHR, an electronic personal ... primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... On Saturday, ... golf outing at the Manistee Golf and Country Club. Best Drug Rehabilitation staff members ... a good cause, helping underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis ...
(Date:7/7/2015)... ... July 07, 2015 , ... On June 22nd-26th, 2015, the ... the National Baptist Convention 110th Annual Session of the National Baptist Congress of ... of churches and their congregations, medical professionals and health-related organizations, this week long ...
Breaking Medicine News(10 mins):Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... soon have a legal framework in place for creating a DNA ... such a database and its admissibility in courts as evidence is ... ,The first draft of the bill is being circulated ... will be presented to the cabinet before it is tabled in ...
... responsible for killing up to half a million Ethiopian ... condition and includes children who are 70 percent or ... height measurements., ,Malnutrition is also a major concern ... What is all the more alarming is that acute ...
... research shows that drinking coffee could decrease the risk ... cohort studies that showed self-reported frequency of coffee consumption ... for potential confounders, researchers say they found that those ... 30 per cent, while those drinking one or more ...
... substitute to her milk’,// . ,Breast feeding has been ... UNICEF and breast feeding steering committees as a socially acceptable ... 1-7)’ comes to an end of weeklong campaign, the United ... many countries. While in some countries it applauds the efforts, ...
... of ones appearance, their a large demand for slimming products ... ,The survey also shows that slimming products in Belgium grew ... a retail value of €29 million. , ,Despite the ... of obesity, the main driver of growth in slimming products ...
... working on using virtual reality to help patients deal ... this research, scientists are creating simulating virtual realities that ... the similar experiences they had felt when they had ... left them unable to cope reality. Called exposure therapy, ...
Cached Medicine News:Health News:DNA Directory Under Construction For Indian Criminals ! 2Health News:With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising 2
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... -- The Global Breast Pumps Market ... at an estimated CAGR of 7.6% from 2014 to 2020, ... Introduction of innovative technologies including hand free breast pumps, growing ... the advantages of breast milk are expected to drive breast ... of untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... , July 7, 2015  Essentialis, a venture-backed company focused ... the treatment of orphan neurobehavioral and metabolic diseases, today announced ... will present a corporate update at the Cantor Fitzgerald Inaugural ... Date: Wednesday, July 8, 2015 Time: 8:00 AM ... About Essentialis, Inc. Essentialis is ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
... 10, 2011 The American Society of Bariatric Physicians (ASBP) ...  Our condolences go out to his family, friends and fans. ... phentermine was a contributing factor to his death are concerning ... medications as prescribed. While the specific details ...
... Sciences International, Inc. (Nasdaq: BDSI ) ... study of a formulation of buprenorphine and naloxone ... technology.   (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) ... to select the final doses of BEMA Buprenorphine/Naloxone ...
Cached Medicine Technology:Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 4
... Practice management software for ... a true multi-tasking, multi-office practice ... in database technology- Winx Pro ... will assist you in effectively ...
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
... offers three-dimensional VCS technology, ... and efficiency in white ... analysis. With its reputation ... HmX is an affordable ...
Medicine Products: